Carcell Biopharma
Latest round
- Seed
Last raised
- Nov 2021
Total raised
- $16M
Investors
- 3
About Carcell Biopharma
Established in 2021 and based in Shanghai, China, Carcell Biopharma is a biomedical company that focuses on research and development of cell and gene therapy. The company was co-founded by Mr. Xiangqian Lin chairman and founder of EVX Ventures and Dr. Jiahai Shi, City University of Hong Kong. The company is headquartered in Shanghai and has a research and development base in Singapore. The company's main products include engineered red blood cell platforms for protein delivery and LNP platforms for nucleic acid delivery. Engineered red blood cell platform to deliver proteins for developing immune tolerance mechanisms in autoimmune diseases. The company will use the pre-series Afunding to advance the red blood cell product to complete IIT clinical trials and advance to IND filing as soon as possible, as well as continue to develop the lipid nanoparticle (LNP) platform with global intellectual property rights.
Who invested in Carcell Biopharma
3 investors across 1 round
See all investors in Carcell Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 2, 2021
Amount
$16M
Investors
Questions about Carcell Biopharma
Who invested in Carcell Biopharma?
Carcell Biopharma has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Carcell Biopharma raised?
Carcell Biopharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Carcell Biopharma last raise money?
Carcell Biopharma's most recent round on record is a Seed, in Nov 2021.
What does Carcell Biopharma do?
Established in 2021 and based in Shanghai, China, Carcell Biopharma is a biomedical company that focuses on research and development of cell and gene therapy.
Where is Carcell Biopharma headquartered?
Carcell Biopharma is headquartered in Shanghai, China.
Which VCs invest in companies like Carcell Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Carcell Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Carcell Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.